Charles & Colvard, Ltd. (NASDAQ:CTHR – Get Free Report) will announce its earnings results after the market closes on Thursday, May 2nd. Individual that wish to register for the company’s earnings conference call can do so using this link.
Charles & Colvard, Ltd. (NASDAQ:CTHR – Get Free Report) last issued its earnings results on Tuesday, February 13th. The company reported ($0.09) earnings per share for the quarter. Charles & Colvard, Ltd. had a negative return on equity of 57.44% and a negative net margin of 91.98%. The company had revenue of $7.91 million for the quarter.
Charles & Colvard, Ltd. Price Performance
Shares of NASDAQ:CTHR traded up $0.01 during midday trading on Tuesday, hitting $0.34. The company had a trading volume of 4,291 shares, compared to its average volume of 117,569. Charles & Colvard, Ltd. has a twelve month low of $0.29 and a twelve month high of $1.03. The business’s 50-day simple moving average is $0.35 and its 200-day simple moving average is $0.38.
Insider Buying and Selling
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on Charles & Colvard, Ltd. in a research note on Wednesday, April 24th. They issued a “hold” rating on the stock.
View Our Latest Research Report on Charles & Colvard, Ltd.
Charles & Colvard, Ltd. Company Profile
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company operates in two segments, Online Channels and Traditional. It manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name.
Featured Articles
- Five stocks we like better than Charles & Colvard, Ltd.
- How to Calculate Stock Profit
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What Investors Need to Know to Beat the Market
- Hilton Demonstrates Asset Light is Right for Investors
- What Are the FAANG Stocks and Are They Good Investments?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Charles & Colvard Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles & Colvard Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.